Overview
- Gender
-
female
- Investor Type
-
Angel
Kimberly Blackwell is the current Chief Executive Officer and Board of Director of Zentalis Pharmaceuticals. She previously worked at Tempus as a Chief Medical Officer and SVP, Clinical Oncology Development. Kimberly Blackwell attended Duke University.
Personal Investments
Kimberly Blackwell has made 1 investments. Their most recent investment was on
Apr 13, 2022, when MoonPay raised $87M.
Date |
Company Name |
Round |
Money Raised |
Industry |
|
Apr 13, 2022 |
MoonPay
|
Series A |
$87M
|
Financial Services |
Detail |